Molbio Diagnostics has updated its Corporate Identification Number following its public listing, officially transitioning its status on the corporate portal from unlisted to listed. This milestone reflects the completion of its exchange debut and marks a key operational shift for retail investors tracking its public market journey.
Molbio Diagnostics Limited has informed the Exchange regarding a press release dated September 07, 2026, titled "Press Release for the Quarter ended June 30, 2026.".
